This webinar spotlights the updates and progress since the January 2021 release of U.S. Food and Drug Administration’s Center for Device and Radiological Health’s (FDA CDRH) AI/ML Action Plan. Each panel focuses on one aspect of the Action plan, starting with an overall framework
for regulating AI, development of Good Machine Learning Practices, and post-market evaluation of AI/ML Software as a Medical Device (SaMD).